Abstract
We investigate the relationship between bias about infectious disease and well-being. First, we empirically establish the existence and the causes of bias, specifically during the COVID-19 pandemic. After that we investigate theoretically the effects of bias on well-being. In order to do this, we present a behavioral-epidemiological differential equation model derived from an agent-based model that combines rational choice behavior with infectious disease dynamics. In addition the model is evaluated normatively by an axiomatically characterized model of an ethical, impartial, eudaimonistic and individualist observer. These assumptions imply a new proof for the utilitarian principle. The result is that while increased fear improves purely epidemiological outcomes, the social welfare outcome shows mixed results; which shows that it is not enough to take only epidemiological measures into account when generating policy recommendations. Finally, we draw some practical consequences from the model, argue, as it pertains to the topic, for protective rights against psychological control by the state, and give some outlooks for future research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research has been conducted as part of the Covid & AI project, which is funded by Ministry of Science and Health of Rhineland-Palatinate, Germany.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Not applicable
